|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Self-powered nanofiber-based screen-print triboelectric sensors for respiratory monitoring显示文摘科学、商业的进展将高要求放为便携电子学。然而,便携电子学的电源供应, breathability,和大量生产仍然有需要被克服的许多挑战。在这研究,一个自我动力的基于 nanofiber 的摩擦电传感器(SNTS ) 被批规模制造技术用 electrospinning 制作并且为经由呼吸监视监视的健康打印屏幕。典型地,一个拱门结构的 SNTS 被 nanofiber 膜和一个 Ag nanoparticle 电极装配。nanofibers 的堆积和 Ag nanoparticles 的传导性的网络越过整个设备保证一条煤气的隧道。当时, SNTS 的煤气的渗透象 6.16 mm/s 一样高,它有压到优势的优点与由密封演员组电影组成的通常使用的便携设备相比。由于 nanofiber 膜的柔软,不管它是否被弄弯,扭曲,或合拢, SNTS 显示出优秀电子输出性能。优异性质 SNTS 的皮友好,自我力量,和批制造例如 breathability,在保健监视和多功能的聪明的系统为他们的申请提供巨大的潜力。 | Ran Cao diaona Wang Shuyu Zhao Wei Yang Zuqing Yuan Yingying Yin Xinyu Du Nian-Wu Li Xiuling Zhang Xiuyan Li Zhong Lin Wang Congju Li | 2018 | Nano Research2018，11，7： | 8 |
| 2 | Relevance of Fourier transform infrared spectroscopy and leaf anatomy for species classification in Camellia 显示文摘 | Lu Hongfei Shen Jinbo Lin Xiuyan | 2008 | Taxon2008，57，4： | 1 |
| 3 | Preparation of Dy-Fe Alloy from Dy2O3 Bymolten Salt Electrochemical Process显示文摘Dy-Fe alloy replace dysprosium in the NdFeB permanent material can improve the performance and productivity and cut the cost.The electrolyte is a binary system of molten DyF3-LiF.Iron is cathode and graphite is anode.The raw material is Dy2O3 oxide.The content of dysprosium is (78 ~85 ) ± 1% in the Dy-Fe alloy made by electrolyzing in the industry producing.In the course of electrolyzing the efficiency of current, the alloy formation and the productivity of rare earths by studying the formation of electrolyte, the electrolyzing temperature, the standards and the current density of cathode, the anode shape etc were studied.The conclusion is that we can produce Dy-Fe alloy (the content of dysprosium is (78 ~ 85 ) ± 1% ) in this condition, the efficiency of current is greater than 68 %, and the productivity of rare earth is greater than 92%.The content of oxygen, calcium, wolfram is smaller than the content by reducing. | Lin Jirong Han Fujun Zhao Liangzhong Zhang Xiuyan Zhao Fei | 2004 | Journal of Rare Earths2004，22，z1： | 1 |
| 4 | Development Trend of Rare Earth Standardion Work显示文摘Rare earth standardization was developed along with rare earth industry.In recent decades, great advances have been made in China rare earth industry.This paper describes the status of rare earth standardization, problems existed and ways to perfect.Now the number of Chinese Rare Earth Standards has increased to 232 with expanding of the categories and covering scope of rare earth products.But the present standard system cannot be completely suited with rare earth production and trade, and not keep pace with the advance of technology.Standards are important rules in world trade and must be acted on. | Ma Jie Lin Jirong Zhao Fei Zhang Xiuyan | 2004 | Journal of Rare Earths2004，22，z1： | 0 |
| 5 | Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells显示文摘SIRT6 belongs to the conserved NAD^(+)-dependent deacetylase superfamily and mediates multiple biological and pathological processes.Targeting SIRT6 by allosteric modulators represents a novel direction for therapeutics,which can overcome the selectivity problem caused by the structural similarity of orthosteric sites among deacetylases.Here,developing a reversed allosteric strategy Allo Reverse,we identified a cryptic allosteric site,Pocket Z,which was only induced by the bi-directional allosteric signal triggered upon orthosteric binding of NAD^(+).Based on Pocket Z,we discovered an SIRT6 allosteric inhibitor named JYQ-42.JYQ-42 selectively targets SIRT6 among other histone deacetylases and effectively inhibits SIRT6 deacetylation,with an IC50 of 2.33μmol/L.JYQ-42 significantly suppresses SIRT6-mediated cancer cell migration and pro-inflammatory cytokine production.JYQ-42,to our knowledge,is the most potent and selective allosteric SIRT6 inhibitor.This study provides a novel strategy for allosteric drug design and will help in the challenging development of therapeutic agents that can selectively bind SIRT6. | Qiufen Zhang Yingyi Chen Duan Ni Zhimin Huang Jiacheng Wei Li Feng Jun-Cheng Su Yingqing Wei Shaobo Ning Xiuyan Yang Mingzhu Zhao Yuran Qiu Kun Song Zhengtian Yu Jianrong Xu Xinyi Li Houwen Lin Shaoyong Lu Jian Zhang | 2022 | Acta Pharmaceutica Sinica B2022，12，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员